PHILADELPHIA, PA, December 7th, 2015 – Dr. Stephen Balter from Columbia University in NYC presented at the 2015 Radiological Society of North America (RSNA) data on an in‐vivo study demonstrating that ControlRad Systems’ radiation dose reducing technology objectively reduced KAP and operator irradiation by 75%. The technology uses state‐of‐the‐art eye‐tracking technology to move semi‐transparent filters in real‐time based on the physician’s gaze. The study was performed at the CRF Skirball Center for Innovation.
“A potential 75% reduction in radiation to patients and physicians during fluoroscopy, especially in complicated interventional cases, will be greatly welcomed,” said Stephen Balter. “Many previous radiation reduction technologies have either reduced image quality and/or impeded workflow. ControlRad’s gaze controlled system has dramatically decreased both patient and staff irradiation and subjectively increased useful image quality; without a significant change in workflow.”
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region of focus of the physician while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Philadelphia and has engineering development facilities in Kfar Saba, Israel. For more information, visit www.controlrad.com.